Paper9856949
Interleukin-13: central mediator of allergic asthma.
Wills-Karp M and 6 others. Science, 1998. Cited by 2,107 papers, by iCite.
Cite this record
ConductScience Library. Interleukin-13: central mediator of allergic asthma. Papers, record 9856949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9856949
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Interleukin-13 | Major topic |
| Allergens | |
| Animals | |
| Bronchial Hyperreactivity | |
| Bronchoalveolar Lavage Fluid | |
| Eosinophils | |
| Goblet Cells | |
| Humans | |
| Immunoglobulin E | |
| Interleukin-13 Receptor alpha1 Subunit | |
| Interleukin-4 | |
| Lung | |
| Male | |
| Mice | |
| Mice, Inbred A | |
| Ovalbumin | |
| Receptors, Interleukin | |
| Receptors, Interleukin-13 | |
| Receptors, Interleukin-4 | |
| Recombinant Fusion Proteins | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL58527 | NHLBI NIH HHS | United States | R01HL058527 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03884842 | Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma. | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9890820 | Interleukin-13's key role in asthma shown. | https://conductscience.org/library/papers/9890820 |
Source PubMed
Cited by888
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,107 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42711600 | Climate Change-Mediated Temperature Extremes: Effects on the Immune System and Associations with Immune-Related Diseases. | Clin Rev Allergy Immunol | 2026 | https://conductscience.org/library/papers/42711600 | PubMed |
| 42598388 | Identification of Novel Small-Molecule Janus Kinase 1 and 2 Inhibitors Through Structure-Based Virtual Screening, In Vitro Assays, and Molecular Dynamics Simulations. | ACS Omega | 2026 | https://conductscience.org/library/papers/42598388 | PubMed |
| 42549070 | Airway smooth muscle in asthma: insights from a transcriptomic meta-analysis. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42549070 | PubMed |
| 42547463 | The Past, the Present, and the Future of Periostin in Allergy. | Allergy Asthma Immunol Res | 2026 | https://conductscience.org/library/papers/42547463 | PubMed |
| 41972134 | The molecular mechanism of circRNA_0021727 in inflammation of eosinophilic chronic rhinosinusitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972134 | PubMed |
| 41581615 | The rhinovirus puzzle: Linking virus and host factors to childhood asthma. | J Allergy Clin Immunol | 2026 | https://conductscience.org/library/papers/41581615 | PubMed |
| 41484668 | Early life group 2 innate lymphoid cells in health and disease. | Mol Cell Pediatr | 2026 | https://conductscience.org/library/papers/41484668 | PubMed |
| 41440490 | Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/41440490 | PubMed |
| 41294800 | A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory Diseases. | Cells | 2025 | https://conductscience.org/library/papers/41294800 | PubMed |
| 41132683 | Immune and inflammatory mechanisms in asthma: insights into epigenetic modifications. | Front Immunol | 2025 | https://conductscience.org/library/papers/41132683 | PubMed |
| 40967603 | T Regulatory Mechanisms in Airway and Interstitial Lung Disease. | Semin Respir Crit Care Med | 2025 | https://conductscience.org/library/papers/40967603 | PubMed |
| 40938898 | Airway sympathectomy attenuates inflammation, transcriptional ratios of Muc5ac and Muc5b, and airway mechanic deficits in mice delivered intranasal IL-13. | Am J Physiol Lung Cell Mol Physiol | 2025 | https://conductscience.org/library/papers/40938898 | PubMed |
| 40822305 | Localised delivery of interleukin-13 from a PLGA microparticle embedded GelMA hydrogel improves functional and histopathological recovery in a mouse contusion spinal cord injury model. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40822305 | PubMed |
| 40775068 | Interleukin 13 signaling modulates dopaminergic functions and nicotine reward in rodents. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/40775068 | PubMed |
| 40732309 | Targeted Biologic Therapies in Severe Asthma: Mechanisms, Biomarkers, and Clinical Applications. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732309 | PubMed |
| 40614216 | Primate retroelement exonization and sexually dimorphic IL13RA1 transcription tune type 2 immune responses. | Sci Immunol | 2025 | https://conductscience.org/library/papers/40614216 | PubMed |
| 40512621 | Airway basal stem cells are necessary for the maintenance of functional intraepithelial airway macrophages. | Cell Rep | 2025 | https://conductscience.org/library/papers/40512621 | PubMed |
| 40446022 | MTOR signaling regulates the development of airway mucous cell metaplasia associated with severe asthma. | JCI Insight | 2025 | https://conductscience.org/library/papers/40446022 | PubMed |
| 40235366 | Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma. | Immunol Rev | 2025 | https://conductscience.org/library/papers/40235366 | PubMed |
| 40170850 | Degradation of IL-4Ralpha by Immunoproteasome: implication in airway type 2 inflammation and hyperresponsiveness. | Front Immunol | 2025 | https://conductscience.org/library/papers/40170850 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| IL5 | 3567 | PubTator's text mining | https://conductscience.org/library/genes/3567 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9856949
GET https://conductscience.org/api/papers/v1/9856949/cited_by?page=2